Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases

IF 3.9 2区 医学 Q2 CELL BIOLOGY
Histopathology Pub Date : 2024-06-03 DOI:10.1111/his.15217
Melad N Dababneh, Christopher C Griffith, Kelly R Magliocca, Ivan J Stojanov
{"title":"Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases","authors":"Melad N Dababneh,&nbsp;Christopher C Griffith,&nbsp;Kelly R Magliocca,&nbsp;Ivan J Stojanov","doi":"10.1111/his.15217","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Background and aims</h3>\n \n <p>Salivary duct carcinoma (SDC) is an aggressive salivary malignancy with multiple morphological subtypes. Primary salivary squamous cell carcinoma (SCC) requires exclusion of high-grade salivary malignancies and metastatic disease and is considered exceptionally rare. We report six cases of SDC with resemblance to SCC on account of variable, but often extensive, squamous differentiation.</p>\n </section>\n \n <section>\n \n <h3> Methods and results</h3>\n \n <p>A retrospective review (2009–2023) at two institutions of SDC with histological and immunophenotypical evidence of squamous differentiation identified six cases. Medical charts and available glass slides were reviewed. There were five males and one female with a median age of 63 years, with tumours involving the parotid (five of six) and submandibular (one of six) glands. All six tumours showed a conventional SDC component comprising &lt; 5–90% of viable tumour. Squamous differentiation comprised 10–95%+ (&gt; 75% in three of six cases) of total viable tumour, and demonstrated CK5/6, p63 and/or p40 immunoexpression in all cases. A sarcomatoid component, comprising 10–60% of viable tumour, was present in three of six (50%) cases. All tumours were androgen receptor (AR)-positive, but only two of six (33.3%) retained AR immunoreactivity in the squamous component. Metastatic SDC to regional lymph nodes exhibited exclusive squamous differentiation in two of six (33.3%) cases.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Squamous differentiation, histologically and immunophenotypically, can be extensive in SDC. AR expression may be lost in the squamous component and metastases may demonstrate only squamous differentiation. These findings cast further doubt on the existence of primary salivary SCC. SDC should be considered whenever encountering a carcinoma with squamous differentiation in major salivary glands or within cervical lymph nodes in the setting of a salivary mass.</p>\n </section>\n </div>","PeriodicalId":13219,"journal":{"name":"Histopathology","volume":null,"pages":null},"PeriodicalIF":3.9000,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/his.15217","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Histopathology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/his.15217","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims

Salivary duct carcinoma (SDC) is an aggressive salivary malignancy with multiple morphological subtypes. Primary salivary squamous cell carcinoma (SCC) requires exclusion of high-grade salivary malignancies and metastatic disease and is considered exceptionally rare. We report six cases of SDC with resemblance to SCC on account of variable, but often extensive, squamous differentiation.

Methods and results

A retrospective review (2009–2023) at two institutions of SDC with histological and immunophenotypical evidence of squamous differentiation identified six cases. Medical charts and available glass slides were reviewed. There were five males and one female with a median age of 63 years, with tumours involving the parotid (five of six) and submandibular (one of six) glands. All six tumours showed a conventional SDC component comprising < 5–90% of viable tumour. Squamous differentiation comprised 10–95%+ (> 75% in three of six cases) of total viable tumour, and demonstrated CK5/6, p63 and/or p40 immunoexpression in all cases. A sarcomatoid component, comprising 10–60% of viable tumour, was present in three of six (50%) cases. All tumours were androgen receptor (AR)-positive, but only two of six (33.3%) retained AR immunoreactivity in the squamous component. Metastatic SDC to regional lymph nodes exhibited exclusive squamous differentiation in two of six (33.3%) cases.

Conclusion

Squamous differentiation, histologically and immunophenotypically, can be extensive in SDC. AR expression may be lost in the squamous component and metastases may demonstrate only squamous differentiation. These findings cast further doubt on the existence of primary salivary SCC. SDC should be considered whenever encountering a carcinoma with squamous differentiation in major salivary glands or within cervical lymph nodes in the setting of a salivary mass.

Abstract Image

鳞状分化的唾液腺导管癌:六例病例的组织形态学和免疫表型分析。
背景和目的:唾液腺导管癌(SDC)是一种侵袭性唾液腺恶性肿瘤,具有多种形态亚型。原发性唾液腺鳞状细胞癌(SCC)需要排除高级别唾液腺恶性肿瘤和转移性疾病,被认为异常罕见。我们报告了六例涎腺鳞状细胞癌(SDC)病例,这些病例与鳞状细胞癌(SCC)相似,但鳞状分化程度不一,而且往往很广泛:方法:两家机构对具有鳞状分化的组织学和免疫表型证据的 SDC 进行了回顾性研究(2009-2023 年),发现了六例病例。研究人员查阅了病历和现有的玻璃切片。其中五男一女,中位年龄为63岁,肿瘤涉及腮腺(六例中的五例)和颌下腺(六例中的一例)。所有六例肿瘤均显示出传统的SDC成分,占总存活肿瘤的75%(六例中的三例),所有病例均显示出CK5/6、p63和/或p40免疫表达。六例中的三例(50%)存在肉瘤成分,占存活肿瘤的 10-60%。所有肿瘤的雄激素受体(AR)均呈阳性,但六个病例中只有两个病例(33.3%)的鳞状成分保留了AR免疫反应。转移至区域淋巴结的 SDC 六例中有两例(33.3%)表现出完全的鳞状分化:结论:从组织学和免疫表型上看,SDC 的鳞状分化可能很广泛。结论:从组织学和免疫表型上看,SDC 的鳞状分化可能很广泛,鳞状部分可能失去 AR 表达,转移灶可能仅表现为鳞状分化。这些发现进一步怀疑了原发性唾液 SCC 的存在。如果在唾液肿块的主要唾液腺或颈淋巴结中发现鳞状分化癌,则应考虑 SDC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Histopathology
Histopathology 医学-病理学
CiteScore
10.20
自引率
4.70%
发文量
239
审稿时长
1 months
期刊介绍: Histopathology is an international journal intended to be of practical value to surgical and diagnostic histopathologists, and to investigators of human disease who employ histopathological methods. Our primary purpose is to publish advances in pathology, in particular those applicable to clinical practice and contributing to the better understanding of human disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信